Skip to main content

Advertisement

Table 1 Clinical characteristics of 90 HCC patients depending on WTAP expression levels

From: WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1

Feture WTAP-high WTAP-low n Χ 2 P
All cases 45 45    
Differentiation     1.113 0.291
 Low 19 24 43   
 High 26 21 47   
AJCC stage     0.194 0.66
 Stage I 30 28 58   
 Stage II & III 15 17 32   
Tumor size     0.809 0.362
 ≤ 5 cm 29 33 62   
 >5 cm 16 12 28   
Tumor encapsulation     3.607 0.045*
 Absent 28 19 47   
 Present 17 26 43   
Microvascular infiltration     0.104 0.747
 Absent 30 28 58   
 Present 10 11 21   
HbsAg     0.338 0.561
 Negative 8 10 18   
 Positive 37 34 71   
HbcAb     0.09 0.765
 Negative 4 3 7   
 Positive 41 39 80   
AFP     0.647 0.421
 ≤ 400 μg/L 27 30 57   
 >400 μg/L 18 14 32   
Recurrence     3.629 0.045*
 No 16 25 41   
 Yes 29 20 49   
  1. Χ2 Test was used to test the association between categorical variables
  2. *Statistically significant